Genepika is dedicated to advancing genetics‑related research, engineering, and product development. Innovations in the field of molecular biology over recent decades have revolutionized the capabilities of genetic tools available to researchers. Applications such as gene editing and drug discovery have extensively explored the potential of oligonucleotide technology for advancing healthcare. One promising application for genetic technology is the development of novel diagnostic tools, significantly accelerated by the onset of the COVID‑19 pandemic. The widespread authorizations of point‑of‑care (POC) diagnostic platforms have demonstrated their importance in resource‑scarce settings and in streamlining clinical services. Clinical data shows that early detection of health conditions via POC devices can greatly improve success rates of treatments, despite these devices having lower sensitivity and accuracy compared to traditional laboratory diagnostics. Although scaled manufacturin...